These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18050291)

  • 21. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
    Yano H; Moran BJ; Cecil TD; Murphy EM
    Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical treatment of a voluminous tumor of the mesenteric root].
    Boisselier P; Foucher F; Boucher E; Raoul JL
    Gastroenterol Clin Biol; 2003 Apr; 27(4):428. PubMed ID: 12759690
    [No Abstract]   [Full Text] [Related]  

  • 23. Total anterior parietal peritonectomy.
    Vazquez Vde L; Sugarbaker PH
    J Surg Oncol; 2003 Aug; 83(4):261-3. PubMed ID: 12884240
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
    Baratti D; Kusamura S; Deraco M
    Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
    [No Abstract]   [Full Text] [Related]  

  • 26. Patient selection for a curative approach to carcinomatosis.
    Piso P; Glockzin G; von Breitenbuch P; Sulaiman T; Popp F; Dahlke M; Esquivel J; Schlitt HJ
    Cancer J; 2009; 15(3):236-42. PubMed ID: 19556910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
    Omohwo C; Nieroda CA; Studeman KD; Thieme H; Kostuik P; Ross AS; Holter DR; Gushchin V; Merriman B; Sardi A
    J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
    Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
    Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenteric pleomorphic liposarcoma in an adolescent.
    Pawel BR; de Chadarévian JP; Inniss S; Kalwinski P; Paul SR; Weintraub WH
    Arch Pathol Lab Med; 1997 Feb; 121(2):173-6. PubMed ID: 9126049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One of the most difficult management problems in surgery is pseudomyxoma peritonei. Foreword.
    Wells SA
    Curr Probl Surg; 2008 Aug; 45(8):521. PubMed ID: 18590841
    [No Abstract]   [Full Text] [Related]  

  • 31. Building on a consensus.
    Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):215-6. PubMed ID: 18726906
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.
    Laterza B; Kusamura S; Baratti D; Oliva GD; Deraco M
    In Vivo; 2009; 23(1):187-90. PubMed ID: 19368148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritonectomy procedures.
    Sugarbaker PH
    Surg Oncol Clin N Am; 2003 Jul; 12(3):703-27, xiii. PubMed ID: 14567026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicystic peritoneal mesothelioma: report of three cases.
    Charfi S; Chetaille B; Marcy M; Turrini O; Chaise De Maison C; Delpero JR; Viret F; Xerri L; Monges G
    Pathologica; 2008 Oct; 100(5):416-9. PubMed ID: 19253604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].
    Tohya T; Ujioka T; Yamaguchi M
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):153-5. PubMed ID: 18195548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
    Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
    Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical management of peritoneal carcinomatosis from colorectal cancer].
    Yano H; Gohda Y; Suda R; Miyake O; Saito Y
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():390-5. PubMed ID: 22213991
    [No Abstract]   [Full Text] [Related]  

  • 38. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin.
    Chang GJ; Lambert LA
    Ann Surg Oncol; 2008 Nov; 15(11):2993-5. PubMed ID: 18787903
    [No Abstract]   [Full Text] [Related]  

  • 39. Laparoscopy in the management of peritoneal carcinomatosis.
    Garofalo A; Valle M
    Cancer J; 2009; 15(3):190-5. PubMed ID: 19556903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Sironi A; Cabras A; Fumagalli L; Laterza B; Deraco M
    In Vivo; 2008; 22(1):153-7. PubMed ID: 18396799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.